Problems of Radiation Medicine and Radiobiology

V. G. Bebeshko, K. M. Bruslova, N. M. Tsvetkova, L. O. Lyashenko, T. I. Pushkariova,
L. O. Gonchar, I. V. Tryhlib, S. M. Yatsemirskyi, Yu. M. Samson, V. G. Boyarskyi,
K. V. Grischenko, V. M. Polyanska, I. V. Dmytrenko

State Institution «National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine», 53 Yuriia Illienka str., Kyiv, 04050, Ukraine

PROGNOSIS OF THE COURSE OF CHORNOBYL-ORIGINATED ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN IN UKRAINE DEPENDING ON THE REASON OF STANDARD CHEMOTHERAPY INTERRUPTION

Objective. Estimation of the bone marrow haemopoietic status depending on the reasons and duration of breaks in a standard chemotherapy (BFM-ALL protocol) to predict the course of acute lymphoblastic leukemia (ALL) in children exposed to low doses of ionizing radiation after the Chornobyl accident.
Materials and methods. The ALL patients (n = 34) were examined within 5 stages of a program chemotherapy. The clinical symptoms, hemogram and myelogram data were analyzed. The radiation dose on bone marrow, initial leukocyte count, variants and prognosis of ALL course were accounted. Days of the stopped chemotherapy, type and frequency of complications (septic processes, febrile neutropenia, toxic hepatitis, granulocytopenia degree), and the prognosis of disease course (child living status, i.e. alive or died) were estimated.
Results. There were abnormal differentiation processes and high percentage of lymphoblasts (86.2 ± 3.3) % in bone marrow in the 1st acute period. Hematological remission was established in all patients on the 33rd day of chemotherapy. In a half of cases the haematopoietic recovery occurred by a granulocyte-monocyte type. One third of patients presenting an erythroid type of haemopoiesis died later. The inverse correlation was found between the number of myelocaryocytes and disease prognosis (rs = -0.49). Breaks in chemotherapy for various reasons were recorded. The number of patients with granulocytopenia was greater at the phase 1 and 2 of protocol I and protocol M application, coinciding with a higher incidence of complications. An inverse correlations between the prediction of ALL course and sum of days of breaks between the protocol M and phase 1 of protocol II (rs = -0.56), as well as the duration of the phase 2 of protocol II (rs = -0.62) were found. The radiation dose on bone marrow was (5.37 ± 1.23) mSv. No relationship was found between the radiation doses, ALL variants and disease course.
Conclusions. Prognosis of ALL course in children depends on the type of haemopoietic recovery and reasons of breaks in a standard chemotherapy. Interaction between the haemopoiesis functioning and microenvironment and that of their regulation are the key mechanisms of above-mentioned abnormalities, which is the basis for further research.
Key words: children, acute lymphoblastic leukemia, hematopoiesis, programmed chemotherapy, causes of breaks, forecast of disease course, ChNPP accident.

Problems of Radiation Medicine and Radiobiology.
2019;24:335-349. doi: 10.33145/2304-8336-2019-24-335-349

full text

1. Nombela-Arrieta C, Manz MG. Quantification and three-dimensional microanatomical organization of the bone marrow. Blood Adv. 2017;1(6):407-16. DOI: 10.1182/bloodadvances.2016003194.

2. Raffaghello L, Ribatti D, Pistoia V. Cancer associated fibroblasts in hematological malignancies. Oncotarget. 2015;6(5):2589-603. DOI: https://doi.org/10.18632/oncotarget.2661

3. Payushina O. V. [Hematopoietic microenvironment and the role of mesenchymal stromal cells in its organization]. Uspekhi Sovremennoi Biologii. 2015;(1):52-63. Russian.

4. American Cancer Society. Treatment of children with acute lymphocytic leukemia (ALL). URL: https://www.cancer.org/cancer/leukemia-in-children/treating/children-with-all.html. Last Medical Review: February 12, 2019 Last Revised: February 12, 2019.

5. Cooper SL., Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):61-73. DOI: 10.1016/j.pcl.2014.09.006.

6. Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int. 2018;60(1):4-12. DOI: https://doi.org/10.1111/ped.13457.

7. Schmiegelow K, Muller K, Mogensen SS, Mogensen PR, Wolthers BO, Stoltze IK, et al. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy Version 1. F1000Res. 2017;(6):444. doi: 10.12688/f1000research.10768.1.

8. Inaba H, Pei D, Wolf J, Howard SC, Hayden RT, Go M, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol. 2017;28(2):386-92. DOI: 10.1093/annonc/mdw557.

9. Canbolat AA, Timur C, Kalaycik O. A retrospective analysis of complications observed in children with acute lymphoblastic leukemia during chemotherapy. Minerva Pediatr. 2017;69(2):95-105. DOI: 10.23736/S0026-4946.16.04239-0.

10. Hough R, Vora A. Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment). Hematology Am Soc Hematol Educ Program. 2017;2017(1):251-258. doi: 10.1182/asheducation-2017.1.251.

11. Ozdemir N, Tuysuz G, Celik N, Yantri L, Erginoz E, Apak H, et al. Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience. Turk Pediatri Ars. 2016;51(2):79-86. DOI: 10.5152/TurkPediatriArs.2016.2757.

12. Dorosh OI, Polischuk RS, Dubay LYa, Tsymbalyuk-Voloshin IP, Vygovska YaI. [Review of complications as causes of breaks in protocol therapy in the treatment of acute lymphoblastic leukemia in children ]. Ukrainskyi Zhurnal Gematolohii ta Transfusiolohii. 2007;4(7):32-6. Ukrainian.

13. Bebeshko VG, Bruslova KM, Pushkareva TI, Tsvyetkova NM, Lyashenko LO, Kuznyetsova OYe, et al. State of erythroid, granulocyte and platelet links of hematopoiesis on stages for chemotherapy in children with acute lymphoblastic leukemia, who were exposed to radiation from the accident at Chornobyl. Probl Radiac Med Radiobiol. 2016;21:178-90.

14. Shiozawa Y, Takita J, Kato M, Sotomatsu M, Koh K, Ida K, Hayashi Y. Prognostic significance of leukopenia in childhood acute lymphoblastic leukemia. Oncol Lett. 2014;7(4):1169-74. DOI: 10.3892/ol.2014.1822.

15. Bebeshko VG, Repin VS, Nechaev SYu, Bruslova KM, Tsvetkova NN, Kuznetsova EE. [Doses of irradiation of the RB marrow and cells of bone surface in children with acute leukemia]. In: Conference "Medical-biological problems of radiation action"; 2012 Apr 10-11; Moscow. Moscow: RAS; 2012. p. 29. Russian.